| 000 | 01388 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512024207.0 | ||
| 264 | 0 | _c19890331 | |
| 008 | 198903s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.297.6663.1574 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKendall-Taylor, P | |
| 245 | 0 | 0 |
_aIntravenous methylprednisolone in the treatment of Graves' ophthalmopathy. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cDec 1988 |
||
| 300 |
_a1574-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraves Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 | _aImmunoglobulins, Thyroid-Stimulating |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aThyroid Gland _ximmunology |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aCrombie, A L | |
| 700 | 1 | _aStephenson, A M | |
| 700 | 1 | _aHardwick, M | |
| 700 | 1 | _aHall, K | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 297 _gno. 6663 _gp. 1574-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.297.6663.1574 _zAvailable from publisher's website |
| 999 |
_c2912106 _d2912106 |
||